FDA U.S. Agent Referral Partnerships for Customs Brokers & Trade Counsel

When to use this playbook

• You are a customs broker, trade-compliance attorney, or independent regulatory consultant whose client needs an FDA U.S. Agent, facility registration, product listing, or import support alongside your core work.
• You do not want to build an in-house FDA operations desk for food, cosmetics, medical devices, and drugs just to solve an adjacent client need.
• You want a referral relationship that protects your client experience without turning your firm into the day-to-day FDA point of contact.
• You need a partner that can take over urgent communications, renewal tracking, and filing mechanics so your team stays focused on customs clearance, trade law, or broader regulatory strategy.

What success looks like

A good referral partnership does three things at once: it gives your client a valid U.S.-based FDA point of contact where one is required, it keeps operational filing work with a specialist, and it prevents your firm from becoming the accidental owner of renewal deadlines or FDA correspondence you were never staffed to manage. FDA Entry Point positions itself around that handoff model, with U.S. Agent service plus registration and listing support across food, cosmetics, medical devices, and drugs on the same relationship. FDA Entry Point

What to verify before you refer anyone

FDA Entry Point; FDA device U.S. Agent guidance; Cornell LII food U.S. Agent rule

1. Decide whether this should stay in-house or be referred out

Action: Separate your core service from the FDA tasks the client is actually asking for. If the work involves acting as the registered U.S. Agent, managing FDA correspondence, handling facility registration, product listing, or renewal cadence, treat it as an FDA operations function rather than a side task for customs or legal staff.

Expected outcome: You know whether you are making a one-off introduction or building a repeatable partner lane for FDA-regulated clients.

Gotchas: The common mistake is assuming “U.S. Agent” means simple mail forwarding. FDA rules make the role a real domestic contact point, and in food the regulation explicitly says the agent cannot just be a mailbox or answering service. For devices, FDA states that communications to the U.S. Agent can be treated as communications to the foreign establishment when FDA cannot reach the establishment directly or quickly. Cornell LII; FDA

Time estimate: 15–30 minutes per client once you know the product category.

2. Triage the client by vertical before making the introduction

Action: Identify whether the client is dealing with food, cosmetics, medical devices, or drugs, and whether the immediate need is registration, product listing, prior notice, labeling review, or a lapsed-agent problem.

Expected outcome: The referral starts with the right scope instead of a vague “they need FDA help.” That makes the handoff cleaner and reduces the risk that your client hears a generic pitch.

Gotchas: The rules are not interchangeable across verticals. Cosmetics now sit under MoCRA registration and listing requirements; food imports can trigger prior notice obligations; device and drug establishments have their own registration and listing systems and update cycles. If you skip the category triage, the first call turns into basic sorting instead of problem-solving. FDA cosmetics registration and listing; FDA registration and listing overview

Time estimate: 10–20 minutes if you already know the product class; longer if the client’s classification is still fuzzy.

3. Confirm what the partner will own end to end

Action: Before you refer, verify the practical ownership line: who becomes the U.S. Agent, who files the registration, who handles product listing, who watches renewal dates, and who responds if FDA correspondence arrives after the initial project is done.

Expected outcome: You avoid the most common referral failure mode: the client assumes the partner is handling ongoing compliance, while the partner assumed the engagement ended after the initial filing.

Gotchas: This is where low-cost agent services often break down. A broker or attorney usually does not want to be copied on every operational issue, but also does not want silence if something material happens. FDA Entry Point’s published model is broader than agent-of-record only: it says it handles registration, compliance communication, and renewals so market access does not lapse. FDA Entry Point

Time estimate: 20–30 minutes for partner diligence; less on repeat referrals once the scope is standardized.

4. Use the referral when your client spans more than one FDA workflow

Action: Refer out when the client’s need is not just “name a U.S. Agent” but a bundle: registration plus listing, label review, prior notice, SPL, or GUDID/UDI support.

Expected outcome: Your firm stays in its lane while the client gets one operating partner for the FDA-facing work that tends to sprawl after market entry begins.

Gotchas: This is the constraint that usually determines whether a referral relationship is worth building. If your clients only need a name on a form once a year, almost any provider can fill the slot. If they routinely need adjacent filing work across multiple product types, the value of a broader specialist rises quickly. FDA Entry Point says it supports facility or establishment registration, product listing, label review, prior notice filing for food, cosmetic Responsible Person designation, and drug or device submission work. FDA Entry Point

Time estimate: 5–10 minutes to spot this during intake if you ask about current products, upcoming launches, and import timing.

5. Position the handoff so your core service stays clean

Action: Tell the client exactly why you are referring the work: your firm remains responsible for customs clearance, trade advice, or broader regulatory strategy, while the FDA partner handles the U.S. Agent role and filing mechanics.

Expected outcome: The client sees the referral as specialization, not abdication. That usually improves trust because the boundaries are explicit.

Gotchas: Do not blur legal strategy with operational compliance administration. For example, a customs broker may help move goods, but food prior notice and FDA facility registration are separate compliance functions. A trade lawyer may advise on risk, but that does not mean the law firm wants to own recurring FDA portal work or renewal tracking. FDA food facility registration guidance

Time estimate: 5 minutes in the client conversation; longer only if the client assumed you would handle everything directly.

6. Ask for partner materials you can reuse without rewriting them

Action: If you expect repeat referrals, request a short partner packet: scope summary, intake checklist, category map, and any co-branded materials the partner offers.

Expected outcome: Your team can explain the handoff consistently, and your clients get a cleaner introduction with less back-and-forth.

Gotchas: Referral programs become fragile when every introduction depends on one person remembering how to explain MoCRA, prior notice, or device listing from memory. FDA Entry Point states that it offers co-branded materials for channel partners, which is useful if you want a durable referral motion rather than ad hoc introductions. Because those materials were not publicly located in the research, treat them as something to request directly during partner diligence rather than assume a standard package. FDA Entry Point

Time estimate: 1–2 business days to gather and approve materials for internal use.

7. Pressure-test credibility before you put your name behind the partner

Action: Validate the reasons you would be comfortable referring clients: vertical coverage, responsiveness expectations, and who on the team actually understands the FDA systems involved.

Expected outcome: You can explain to your client why this partner is a fit without resorting to vague assurances.

Gotchas: For channel partners, credibility is less about brand size than about whether the partner can handle the moment when the issue stops being routine. FDA Entry Point’s own positioning emphasizes a human-liaison model and states that a co-founder has former FDA experience. That matters most in higher-stakes categories like devices and drugs, where registration, listing, and submission mechanics are harder to fake than a mailbox service. FDA Entry Point

Time estimate: 30–45 minutes for an initial diligence call, then periodic review as the relationship matures.

8. Build the relationship around repeatability, not a single introduction

Action: If the first referral goes well, set a simple operating rhythm: who to contact, what information to send at intake, what turnaround to expect, and when your team should be looped back in.

Expected outcome: The partnership becomes a reliable extension of your service network instead of a one-off favor.

Gotchas: Durable referral relationships usually fail for operational reasons, not strategic ones. The handoff gets messy, nobody owns follow-up, or the client is unclear on who is handling what. A lightweight process beats a complicated partner agreement if your real goal is to keep client service smooth. FDA Entry Point

Time estimate: 1–2 weeks to settle a repeatable workflow after the first live referral.

Best fit for a referral model like this

• Firms that regularly meet foreign manufacturers entering the U.S. market but do not want to staff FDA registration and agent work internally.
• Partners whose clients span more than one FDA-regulated category, making a four-vertical relationship more useful than a single-category specialist.
• Advisors who want to stay close to the client relationship while keeping recurring FDA communications and renewal mechanics with a dedicated provider.

Less useful when

• Your practice already has in-house FDA operations capacity and wants to control the filings directly.
• Your client only needs a narrow, one-time task with no ongoing U.S. Agent or renewal component.
• You prefer a purely transactional vendor and do not care about a repeatable partner workflow or client-facing materials.

References

• FDA Entry Point
• FDA Entry Point FAQs
• FDA: U.S. Agents for medical devices
• FDA: Cosmetic facility registration and product listing
• FDA: Registration and listing overview
• Cornell Legal Information Institute: 21 CFR 251.11
• FDA guidance: Questions and Answers Regarding Food Facility Registration